Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis C treatment news

Show

From To
Egypt targets hepatitis C patients for medical tourism

In mid 2016, Prime Pharma, a private Egyptian pharmaceutical company, launched Tour n’ Cure to revive therapeutic tourism in Egypt. The first target is hepatitis C patients from around the world. Countries targeted are Spain, Belgium, Italy, Netherlands and the UK.

Published
24 February 2017
From
International Medical Tourism Journal
Messi visits Egypt to promote Hepatitis C treatment

Supported by the Egyptian ministries of tourism and aviation, Prime Pharma started a campaign titled “Tour n’ Cure” to promote tourism treatment in Egypt, with Messi being chosen as ambassador for the campaign worldwide.

Published
22 February 2017
From
Daily News Egypt
Deal reduces price of life-saving hepatitis C drugs for Canadians

Tens of thousands of Canadian patients with mild versions of chronic hepatitis C could soon receive public funding for medications that cure the infection now that the provinces have sealed a deal with three pharmaceutical companies to reduce the cost of the ultra-expensive drugs.

Published
22 February 2017
From
The Globe and Mail
SF working on ambitious plan to eliminate hepatitis C

San Francisco is trying to become the first city in the nation to eliminate hepatitis C, rolling out an ambitious plan that would involve curing everyone who already has it and stopping further spread of the infectious disease, which can cause severe liver damage.

Published
21 February 2017
From
San Francisco Chronicle
Hepatitis C will be eradicated in Australia by 2026, researchers predict

More than 30,000 people were treated for hepatitis C last year, according to a report published by the Kirby Institute at the University of New South Wales. The report found Australia was in a position to eradicate the disease by 2026.

Published
21 February 2017
From
ABC Online
New hepatitis C infections among HIV-positive gay men drop by half after direct-acting antiviral roll-out in Netherlands

A little more than a year after the Netherlands instituted a policy allowing unrestricted access to direct-acting antivirals for the treatment of hepatitis C, researchers have already

Published
17 February 2017
By
Liz Highleyman
Curing hepatitis C reduces the risk of diabetes & kidney failure in people with HIV/HCV co-infection

Curing hepatitis C infection substantially reduces the risk of developing type 2 diabetes in people with HIV/hepatitis C virus (HCV) co-infection, but does not reduce

Published
01 February 2017
By
Keith Alcorn
HCV eradication in HIV coinfected patients linked to reduced diabetes, chronic renal failure

Eradication of hepatitis C virus infection among patients coinfected with HIV was associated with reductions in diabetes and chronic renal failure in addition to reduced mortality, HIV progression and liver-related events, according to the results of a Spanish cohort study. These findings led investigators to conclude that HIV coinfected patients should receive HCV therapy regardless of their fibrosis stage.

Published
31 January 2017
From
Healio
Report Cites Liver Failure Risk With New Hepatitis C Drugs

A new report questions the safety of some of the new drugs found to cure hepatitis C, in light of findings of liver failure and injury. But hepatitis C virus (HCV) experts say the findings are inconclusive, should be interpreted with great caution, and should not influence prescribing.

Published
31 January 2017
From
Medscape
Liver cirrhosis and decompensation still on the rise among people with hepatitis C

Complications of advanced liver disease including cirrhosis and hepatic decompensation have risen over the past decade among people with chronic hepatitis C, according to study

Published
31 January 2017
By
Liz Highleyman
← First12345...87Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.